liver cancer
Conditions
Interventions
1.Patients who underwent hepatoma resection:None
Sponsors
Shengjing Hospital affiliated to China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients who underwent hepatoma resection in Shengjing Hospital from January 1, 2015 to December 31, 2023 were selected 2.Elective hepatectomy was performed 3. ASA grade I~III
Exclusion criteria
Exclusion criteria: 1. Biochemical examinations were not completed before surgery 2. Emergency operation 3. A short history of irrational blood transfusion before surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative blood transfusion;Preoperative hemoglobin content;Preoperative hematocrit;Preoperative serum total protein;Preoperative serum albumin;Preoperative serum prealbumin;Preoperative platelet;Mean preoperative platelet volume;Preoperative coagulation function;Preoperative concentration of alpha-fetoprotein;History of preoperative abdominal surgery;Intraoperative blood loss;Type and dosage of blood products transfused during operation;Type and dosage of blood products transfused after operation;Types and doses of postoperative transfusion products;Tumor size and location; | — |
Secondary
| Measure | Time frame |
|---|---|
| Preoperative thrombologram;Preoperative total bilirubin;Preoperative direct bilirubin;Preoperative indirect bilirubin;Preoperative use of anticoagulant drugs;Preoperative underlying disease;Time of operation;Postoperative hospital stay;Postoperative complications; | — |
Countries
China
Contacts
Public ContactBo Long
Shengjing Hospital affiliated to China Medical University
Outcome results
None listed